ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Rubius Therapeutics, Inc. (RUBY) stock surged +2.70%, trading at $0.06 on NASDAQ, up from the previous close of $0.06. The stock opened at $0.06, fluctuating between $0.06 and $0.06 in the recent session.
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Employees | 6 |
Beta | 2.21 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Rubius Therapeutics, Inc. (NASDAQ: RUBY) stock price is $0.06 in the last trading session. During the trading session, RUBY stock reached the peak price of $0.06 while $0.06 was the lowest point it dropped to. The percentage change in RUBY stock occurred in the recent session was 2.7% while the dollar amount for the price change in RUBY stock was $0.00.
The NASDAQ listed RUBY is part of Biotechnology industry that operates in the broader Healthcare sector. Rubius Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Marissa Hanify
Director of Corporation Communications
Dr. Laurence A. Turka M.D.
Chief Scientific Officer and Head of Research & Translational Medicine
Ms. Dannielle Appelhans
Chief Executive Officer & Pres
RUBY's closing price is 1,681.25% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.38 is -84.85%.
Number of RUBY employees currently stands at 6.
Official Website of RUBY is: https://www.rubiustx.com
RUBY could be contacted at phone 617 679 9600 and can also be accessed through its website. RUBY operates from 399 Binney Street, Cambridge, MA 02139, United States.
RUBY stock volume for the day was 755.86K shares. The average number of RUBY shares traded daily for last 3 months was 99.54K.
The market value of RUBY currently stands at $0.00 with its latest stock price at $0.06 and 0 of its shares outstanding.